Cargando…
Biosimilar Drugs: What Would Be a Reasonable Extrapolation?
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180803/ https://www.ncbi.nlm.nih.gov/pubmed/30241152 http://dx.doi.org/10.1200/JGO.2016.008342 |
_version_ | 1783362285915340800 |
---|---|
author | Gifoni, Markus A.C. Fernandes, Gustavo S. Chammas, Roger |
author_facet | Gifoni, Markus A.C. Fernandes, Gustavo S. Chammas, Roger |
author_sort | Gifoni, Markus A.C. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6180803 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | American Society of Clinical Oncology |
record_format | MEDLINE/PubMed |
spelling | pubmed-61808032018-11-13 Biosimilar Drugs: What Would Be a Reasonable Extrapolation? Gifoni, Markus A.C. Fernandes, Gustavo S. Chammas, Roger J Glob Oncol Commentaries American Society of Clinical Oncology 2017-05-09 /pmc/articles/PMC6180803/ /pubmed/30241152 http://dx.doi.org/10.1200/JGO.2016.008342 Text en © 2017 by American Society of Clinical Oncology http://creativecommons.org/licenses/by/4.0/ Licensed under the Creative Commons Attribution 4.0 License: http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Commentaries Gifoni, Markus A.C. Fernandes, Gustavo S. Chammas, Roger Biosimilar Drugs: What Would Be a Reasonable Extrapolation? |
title | Biosimilar Drugs: What Would Be a Reasonable
Extrapolation? |
title_full | Biosimilar Drugs: What Would Be a Reasonable
Extrapolation? |
title_fullStr | Biosimilar Drugs: What Would Be a Reasonable
Extrapolation? |
title_full_unstemmed | Biosimilar Drugs: What Would Be a Reasonable
Extrapolation? |
title_short | Biosimilar Drugs: What Would Be a Reasonable
Extrapolation? |
title_sort | biosimilar drugs: what would be a reasonable
extrapolation? |
topic | Commentaries |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180803/ https://www.ncbi.nlm.nih.gov/pubmed/30241152 http://dx.doi.org/10.1200/JGO.2016.008342 |
work_keys_str_mv | AT gifonimarkusac biosimilardrugswhatwouldbeareasonableextrapolation AT fernandesgustavos biosimilardrugswhatwouldbeareasonableextrapolation AT chammasroger biosimilardrugswhatwouldbeareasonableextrapolation |